One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion

PURPOSE: To report the 12-month efficacy and safety outcomes of intravitreal ziv-aflibercept in macular edema secondary to central retinal vein occlusion (CRVO). METHODS: Interventional case series documenting 12-month outcomes of intravitreal ziv-aflibercept (1.25 mg in 0.05 mL) in 6 patients with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Ophthalmol Case Rep
Autori principali: Eldeeb, Mohab, Chan, Errol W., Dedhia, Chintan J., Mansour, Ahmad, Chhablani, Jay
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2017
Soggetti:
Case report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5731707/
https://ncbi.nlm.nih.gov/pubmed/29260119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2017.10.011
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi